These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1598097)

  • 21. Identification of two novel mutations of the carnitine/acylcarnitine translocase (CACT) gene in a patient with CACT deficiency.
    Ogawa A; Yamamoto S; Kanazawa M; Takayanagi M; Hasegawa S; Kohno Y
    J Hum Genet; 2000; 45(1):52-5. PubMed ID: 10697964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A patient with carnitine-acylcarnitine translocase deficiency with a mild phenotype.
    Morris AA; Olpin SE; Brivet M; Turnbull DM; Jones RA; Leonard JV
    J Pediatr; 1998 Mar; 132(3 Pt 1):514-6. PubMed ID: 9544911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in carnitine-acylcarnitine translocase activity and in phospholipid composition in heart mitochondria from hypothyroid rats.
    Paradies G; Ruggiero FM; Petrosillo G; Quagliariello E
    Biochim Biophys Acta; 1997 Dec; 1362(2-3):193-200. PubMed ID: 9540850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carnitine-acylcarnitine translocase deficiency: implications in human pathology.
    Pande SV; Murthy MS
    Biochim Biophys Acta; 1994 Jul; 1226(3):269-76. PubMed ID: 8054358
    [No Abstract]   [Full Text] [Related]  

  • 25. Fatty acyl group transport into mitochondria: carnitine palmitoyl transferases EC 2.3.1.23 and the carnitine-acylcarnitine translocase.
    Halperin ML; Pande SV
    Methods Enzymol; 1979; 56():368-78. PubMed ID: 459872
    [No Abstract]   [Full Text] [Related]  

  • 26. Retrospective diagnosis of carnitine-acylcarnitine translocase deficiency by acylcarnitine analysis in the proband Guthrie card and enzymatic studies in the parents.
    Brivet M; Slama A; Millington DS; Roe CR; Demaugre F; Legrand A; Boutron A; Poggi F; Saudubray JM
    J Inherit Metab Dis; 1996; 19(2):181-4. PubMed ID: 8739960
    [No Abstract]   [Full Text] [Related]  

  • 27. Carnitine-acylcarnitine translocase deficiency.
    Pande SV
    Am J Med Sci; 1999 Jul; 318(1):22-7. PubMed ID: 10408757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carnitine-acylcarnitine translocase deficiency. Clinical course of 3 Saudi children with a severe phenotype.
    Al-Mendalawi MD
    Saudi Med J; 2011 Feb; 32(2):203; author reply 203. PubMed ID: 21301774
    [No Abstract]   [Full Text] [Related]  

  • 29. Pre-eclampsia in a woman whose child suffered from lethal carnitine-acylcarnitine translocase deficiency.
    Geven WB; Niezen-Koning KE; Timmer A; van Loon AJ; Wanders RJ; van Spronsen FJ
    BJOG; 2007 Aug; 114(8):1028-30. PubMed ID: 17578469
    [No Abstract]   [Full Text] [Related]  

  • 30. Differential carnitine/acylcarnitine translocase expression defines distinct metabolic signatures in skeletal muscle cells.
    Peluso G; Petillo O; Margarucci S; Grippo P; Melone MA; Tuccillo F; Calvani M
    J Cell Physiol; 2005 May; 203(2):439-46. PubMed ID: 15515015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity of cephaloridine to carnitine transport and fatty acid metabolism in rabbit renal cortical mitochondria: structure-activity relationships.
    Tune BM; Hsu CY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):873-80. PubMed ID: 7932199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria.
    Lamhonwah AM; Tein I
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1315-25. PubMed ID: 16729965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of carnitine acylcarnitine translocase activity in heart mitochondria from hyperthyroid rats.
    Paradies G; Ruggiero FM; Petrosillo G; Quagliariello E
    FEBS Lett; 1996 Nov; 397(2-3):260-2. PubMed ID: 8955359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Carnitine/acylcarnitine translocase deficiency].
    Yorifuji S
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):403-4. PubMed ID: 9590083
    [No Abstract]   [Full Text] [Related]  

  • 35. Carnitine-acylcarnitine translocase activity in cardiac mitochondria from aged rats: the effect of acetyl-L-carnitine.
    Paradies G; Ruggiero FM; Petrosillo G; Gadaleta MN; Quagliariello E
    Mech Ageing Dev; 1995 Oct; 84(2):103-12. PubMed ID: 8788238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carnitine-acylcarnitine translocase deficiency is a treatable disease.
    al Aqeel AI; Rashed MS; Wanders RJ
    J Inherit Metab Dis; 1999 May; 22(3):271-5. PubMed ID: 10384385
    [No Abstract]   [Full Text] [Related]  

  • 37. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medium-chain triglyceride loading test in carnitine-acylcarnitine translocase deficiency: insights on treatment.
    Parini R; Invernizzi F; Menni F; Garavaglia B; Melotti D; Rimoldi M; Salera S; Tosetto C; Taroni F
    J Inherit Metab Dis; 1999 Aug; 22(6):733-9. PubMed ID: 10472533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic interactions between peroxisomes and mitochondria with a special focus on acylcarnitine metabolism.
    Houten SM; Wanders RJA; Ranea-Robles P
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165720. PubMed ID: 32057943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Carnitine: its role and its action in disease].
    Pande SV
    Union Med Can; 1977 Apr; 106(4):538-42. PubMed ID: 324069
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.